Silk Fibroin Bioink for 3D Printing in Tissue Regeneration: Controlled Release of MSC extracellular Vesicles.

3D bioprinting MSC-extracellular vesicles MSC-secretome bioink controlled release silk fibroin sodium alginate

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
22 Jan 2023
Historique:
received: 20 12 2022
revised: 16 01 2023
accepted: 20 01 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 26 2 2023
Statut: epublish

Résumé

Sodium alginate (SA)-based hydrogels are often employed as bioink for three-dimensional (3D) scaffold bioprinting. They offer a suitable environment for cell proliferation and differentiation during tissue regeneration and also control the release of growth factors and mesenchymal stem cell secretome, which is useful for scaffold biointegration. However, such hydrogels show poor mechanical properties, fast-release kinetics, and low biological performance, hampering their successful clinical application. In this work, silk fibroin (SF), a protein with excellent biomechanical properties frequently used for controlled drug release, was blended with SA to obtain improved bioink and scaffold properties. Firstly, we produced a printable SA solution containing SF capable of the conformational change from Silk I (random coil) to Silk II (β-sheet): this transition is a fundamental condition to improve the scaffold's mechanical properties. Then, the SA-SF blends' printability and shape fidelity were demonstrated, and mechanical characterization of the printed hydrogels was performed: SF significantly increased compressive elastic modulus, while no influence on tensile response was detected. Finally, the release profile of Lyosecretome-a freeze-dried formulation of MSC-secretome containing extracellular vesicles (EV)-from scaffolds was determined: SF not only dramatically slowed the EV release rate, but also modified the kinetics and mechanism release with respect to the baseline of SA hydrogel. Overall, these results lay the foundation for the development of SA-SF bioinks with modulable mechanical and EV-release properties, and their application in 3D scaffold printing.

Identifiants

pubmed: 36839705
pii: pharmaceutics15020383
doi: 10.3390/pharmaceutics15020383
pmc: PMC9959026
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Interreg V-A Italy-Switzerland 2014-2020
ID : ATEx-Advanced Therapies Experiences. Project ID 3859153
Organisme : Italian Ministry of Health
ID : Project MINSAL_INVITRO_TUMOR, CUP E85F21003590001

Références

Stem Cells Int. 2016;2016:7564689
pubmed: 28090208
J Biol Eng. 2015 Mar 01;9:4
pubmed: 25866560
Int J Mol Sci. 2018 Mar 29;19(4):
pubmed: 29596323
Int J Pharm. 2019 Apr 5;560:175-190
pubmed: 30763681
Biomaterials. 2017 Jul;134:180-201
pubmed: 28477541
Pharm Acta Helv. 1985;60(4):110-1
pubmed: 4011621
Biomaterials. 2005 Jan;26(2):147-55
pubmed: 15207461
PLoS One. 2007 Jun 13;2(6):e514
pubmed: 17565367
Gels. 2022 Feb 27;8(3):
pubmed: 35323260
Proteins. 2007 Jul 1;68(1):223-31
pubmed: 17436322
J Mech Behav Biomed Mater. 2018 Mar;79:150-157
pubmed: 29304429
Biofabrication. 2017 Nov 14;9(4):044107
pubmed: 28930091
J Pharm Biomed Anal. 2020 Jul 15;186:113291
pubmed: 32334133
Pharmaceutics. 2021 Apr 08;13(4):
pubmed: 33918073
Nat Protoc. 2011 Sep 22;6(10):1612-31
pubmed: 21959241
Biomaterials. 2010 Jan;31(2):308-14
pubmed: 19782393
Pharmaceuticals (Basel). 2022 Oct 19;15(10):
pubmed: 36297394
Cells. 2021 Jul 11;10(7):
pubmed: 34359919
Eur J Pharm Biopharm. 2020 Oct;155:37-48
pubmed: 32784044
Biomaterials. 2001 Mar;22(6):511-21
pubmed: 11219714
J Biomed Mater Res. 1999 Sep 5;46(3):382-9
pubmed: 10397996
Biomedicines. 2022 May 03;10(5):
pubmed: 35625800
Polymers (Basel). 2022 Jul 20;14(14):
pubmed: 35890705
Macromol Biosci. 2008 Nov 10;8(11):1006-18
pubmed: 18629803
Adv Healthc Mater. 2021 Apr;10(7):e2001948
pubmed: 33594836
Nat Rev Mater. 2016 Dec;1(12):
pubmed: 29657852
Biomaterials. 2010 Aug;31(24):6121-30
pubmed: 20478613
Crit Rev Biotechnol. 2017 May;37(3):333-354
pubmed: 27023266
PLoS One. 2015 Sep 29;10(9):e0139424
pubmed: 26418001
J Zhejiang Univ Sci B. 2010 Jan;11(1):10-6
pubmed: 20043346
Chem Rev. 2020 Oct 14;120(19):11028-11055
pubmed: 32856892
Int J Biol Macromol. 2016 Dec;93(Pt B):1420-1431
pubmed: 27156697
Biomacromolecules. 2011 Sep 12;12(9):3344-9
pubmed: 21790142
Nature. 2003 Aug 28;424(6952):1057-61
pubmed: 12944968
Adv Healthc Mater. 2021 Jan;10(1):e2001341
pubmed: 33073515
NPJ Regen Med. 2021 Mar 29;6(1):18
pubmed: 33782415
Materials (Basel). 2019 Feb 06;12(3):
pubmed: 30736388
J Control Release. 2014 Sep 28;190:75-81
pubmed: 24998939
ACS Appl Mater Interfaces. 2018 Mar 28;10(12):9969-9979
pubmed: 29451384
J Mech Behav Biomed Mater. 2023 Feb;138:105598
pubmed: 36455380
Acta Biomater. 2021 Apr 15;125:57-71
pubmed: 33601067
J Tissue Eng Regen Med. 2021 Sep;15(9):747-762
pubmed: 34058083
J Am Chem Soc. 2004 Nov 10;126(44):14350-1
pubmed: 15521743
J R Soc Interface. 2011 Feb 6;8(55):153-70
pubmed: 20719768
Eur J Pharm Biopharm. 2019 Apr;137:37-45
pubmed: 30772432
Int J Nanomedicine. 2014 Sep 23;9:4507-20
pubmed: 25285004
Mater Sci Eng R Rep. 2017 Jan;111:1-26
pubmed: 28649171
Biomaterials. 2005 Jun;26(17):3385-93
pubmed: 15621227
Cells. 2018 Oct 30;7(11):
pubmed: 30380806
Materials (Basel). 2015 Feb 16;8(2):799-814
pubmed: 28787971
Biomacromolecules. 2012 Mar 12;13(3):826-32
pubmed: 22320432
Stem Cells Int. 2017;2017:6367375
pubmed: 28243258
Int J Mol Sci. 2022 Nov 23;23(23):
pubmed: 36498949
Int J Mol Sci. 2022 Mar 27;23(7):
pubmed: 35409025
Biomaterials. 2003 Aug;24(18):3079-85
pubmed: 12895580
Prog Polym Sci. 2007;32(8-9):991-1007
pubmed: 19543442
Acta Biomater. 2022 Oct 15;152:300-312
pubmed: 36055606
BMB Rep. 2011 Dec;44(12):787-92
pubmed: 22189681
Int J Biol Macromol. 2003 Dec;33(4-5):203-13
pubmed: 14607365

Auteurs

Elia Bari (E)

Department of Pharmaceutical Sciences, University of Piemonte Orientale, Largo Donegani 2/3, 28100 Novara, Italy.

Giulia Maria Di Gravina (GM)

Department of Industrial and Information Engineering, University of Pavia, Via Ferrata 5, 27100 Pavia, Italy.

Franca Scocozza (F)

Department of Civil Engineering and Architecture, University of Pavia, Via Ferrata 3, 27100 Pavia, Italy.

Sara Perteghella (S)

Department of Drug Sciences, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy.
PharmaExceed s.r.l., Piazza Castello 19, 27100 Pavia, Italy.

Benedetta Frongia (B)

Department of Civil Engineering and Architecture, University of Pavia, Via Ferrata 3, 27100 Pavia, Italy.

Sara Tengattini (S)

Department of Drug Sciences, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy.

Lorena Segale (L)

Department of Pharmaceutical Sciences, University of Piemonte Orientale, Largo Donegani 2/3, 28100 Novara, Italy.

Maria Luisa Torre (ML)

Department of Pharmaceutical Sciences, University of Piemonte Orientale, Largo Donegani 2/3, 28100 Novara, Italy.
PharmaExceed s.r.l., Piazza Castello 19, 27100 Pavia, Italy.

Michele Conti (M)

Department of Civil Engineering and Architecture, University of Pavia, Via Ferrata 3, 27100 Pavia, Italy.

Classifications MeSH